Acta Chir Orthop Traumatol Cech. 2017; 84(1):24-29 | DOI: 10.55095/achot2017/003

Delayed Fracture Healing in Diabetics with Distal Radius FracturesOriginal papers

S. PSCHERER1,*, G. H. SANDMANN2, S. EHNERT3, A. K. NUSSLER3, U. STÖCKLE3, T. FREUDE3
1 Abteilung für Innere Medizin-Diabetologie, Klinikum Traunstein, Traunstein, Germany
2 Klinik und Poliklinik für Unfallchirurgie, Klinikum rechts der Isar, Technische Universität München, München, Germany
3 Berufsgenossenschaftliche Unfallklinik Tübingen, Eberhard Karls Universität Tübingen, Tübingen, Germany

PURPOSE OF THE STUDY:
Diabetics may have an increased fracture risk, depending on disease duration, quality of metabolic adjustment and extent of comorbidities, and on an increased tendency to fall. The aim of this retrospective one-centre study consisted in detecting differences in fracture healing between patients with and without diabetes mellitus. Data of patients with the most common fracture among older patients were analyzed.

MATERIAL AND METHODS:
Classification of distal radius fractures was established according to the AO classification. Inital assessment and follow-up were made by conventional x-rays with radiological default settings. To evaluate fracture healing, formation of callus and sclerotic border, assessment of the fracture gap, and evidence of consolidation signs were used.

RESULTS:
The authors demonstrated that fracture morphology does not influence fracture healing regarding time span, neither concerning consolidation signs nor in fracture gap behavior. However, tendency for bone remodeling is around 70% lower in investigated diabetics than in non-diabetics, while probability for a successful fracture consolidation is 60% lower.

CONCLUSIONS:
To corroborate the authors hypothesis of delayed fracture healing in patients with diabetes mellitus, prospective studies incorporating influencing factors like duration of metabolic disease, quality of diabetes control, medical diabetes treatment, comorbidities and secondary diseaseas, like chronic nephropathy and osteoporosis, have to be carried out.

Keywords: diabetes, delayed fracture healing, distal radius fractures, callus formation, blood glucose level, osteoblasts

Published: February 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
PSCHERER S, SANDMANN GH, EHNERT S, NUSSLER AK, STÖCKLE U, FREUDE T. Delayed Fracture Healing in Diabetics with Distal Radius Fractures. Acta Chir Orthop Traumatol Cech. 2017;84(1):24-29. doi: 10.55095/achot2017/003. PubMed PMID: 28253942.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Blakytny R, Spraul M, Jude EB. Review: The diabetic bone: a cellular and molecular perspective. Int J Low Extrem Wounds. 2011;10:16-32. Go to original source... Go to PubMed...
    2. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318:1315-1321. Go to original source... Go to PubMed...
    3. Cerami A, Vlassara H, Brownlee M. Role of advanced glycosylation products in complications of diabetes. Diabetes Care. 1988;11(Suppl. 1):73-79.
    4. Flodin L, Sääf M, Cederholm T, Al-Ani AN, Ackermann PW, Samnegård E, Dalen N, Hedström M. Additive effects of nutritional supplementation together with bisphosphonates on bone mineral density after hip fracture: a 12-month randomized controlled study. Clin Interv Aging. 2014;9:1043-1050. Go to original source... Go to PubMed...
    5. Freude T, Braun KF, Haug A, Pscherer S, Stöckle U, Nüssler AK, Ehnert S. Hyperinsulinemia reduces osteoblast activity in vitro via upregulation of TGF-beta. J Mol Med (Berl). 2012;90:1257-1266. Go to original source... Go to PubMed...
    6. Heath H 3rd, Melton LJ 3rd, Chu CP. Diabetes mellitus and risk of skeletal fracture. N Engl J Med. 1980;303:567-570. Go to original source... Go to PubMed...
    7. Hopps E, Caimi G. Exercise in obesity management. J Sports Med Phys Fitness. 2011;51:275-282. Go to PubMed...
    8. Hwang YC, Jeong IK, Ahn KJ, Chung HY. Circulating osteocalcin level is associated with improved glucose tolerance insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporos Int. 2012;23: 1337-1342. Go to original source... Go to PubMed...
    9. IDF Diabetes atlas. 6th edition, 2013, IDF.
    10. Kasahara T, Imai S, Kojima H, Katagi M, Kimura H, Chan L, Matsusue Y. Malfunction of bone marrow-derived osteoclasts and the delay of bone fracture healing in diabetic mice. Bone. 2010;47:617-625. Go to original source... Go to PubMed...
    11. Katayama Y, Akatsu T, Yanamoto M, Kugai N, Nagata N. Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. J Bone Miner Res. 1996;11:931-937. Go to original source... Go to PubMed...
    12. Khazai NB, Beck GR Jr, Umpierrez GE. Diabetes and fractures: an overshadowed association. Curr Opin Endocrinol Diabetes Obes. 2009;16:435-445. Go to original source... Go to PubMed...
    13. Kidder LS, Chen X, Schmidt AH, Lew WD. Osteogenic protein-1 overcomes inhibition of fracture healing in the diabetic rat: a pilot study. Clin Orthop Relat Res. 2009;467:3249-3256. Go to original source... Go to PubMed...
    14. Krakauer JC, Mckenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM. Bone loss and bone turnover in diabetes. Diabetes. 1995;44: 775-782. Go to original source... Go to PubMed...
    15. La Fontaine J, Shibuya N, Sampson HW, Valderrama P. Trabecular quality and cellular characteristics of normal diabetic and Charcot bone. J Foot Ankle Surg. 2011;50:648-653. Go to original source... Go to PubMed...
    16. Lecka-Czernik B. Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis. Curr Osteoporos Rep. 2010;8:178-184. Go to original source... Go to PubMed...
    17. Leslie WD, Lix LM, Prior HJ, Derksen S, Metge C, O Neil J. Biphasic fracture risk in diabetes: a population-based study. Bone. 2007;40:1595-1601. Go to original source... Go to PubMed...
    18. Leslie WD, Rubin MR, Schwartz AV, Kanis JA. Type 2 diabetes and bone. J Bone Miner Res. 2012;27:2231-2237. Go to original source... Go to PubMed...
    19. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Ekoyan G, National Kidney Federation.National Kidney Foundation practice guidelines for chronic kidney disease: evaluation classification and stratification. Ann Intern Med. 2003;139: 137-147. Go to original source... Go to PubMed...
    20. Meier C, Kraenzlin ME, Bodmer M, Jick SS, Jick H, Meier CR. Use of thiazolidinediones and fracture risk. Arch Intern Med. 2008;168:820-825. Go to original source... Go to PubMed...
    21. Melton LJ 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res. 2008;23:1334-1342. Go to original source... Go to PubMed...
    22. Miyata T, Notoya K, Yoshida K, Horie K, Maeda K, Kurokawa K, Taketomi S. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol. 1997;8: 260-270. Go to original source... Go to PubMed...
    23. Molinuevo MS, Schurman L, Mccarthy AD, Cortizo AM, Tolosa MJ, Gangoiti MV, Arnol V, Sedlinsky C. Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies. J Bone Miner Res. 2010;25:211-221. Go to original source... Go to PubMed...
    24. Mosekilde L. Vitamin D and the elderly. Clin Endocrinol. 2005;62:265-281. Go to original source... Go to PubMed...
    25. Norris R, Parker M. Diabetes mellitus and hip fracture: a study of 5966 cases. Injury. 2011;42: 1313-1316. Go to original source... Go to PubMed...
    26. Paul RG, Bailey AJ. Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. Int J Biochem Cell Biol. 1996;28:1297-1310. Go to original source... Go to PubMed...
    27. Pscherer S, Freude T, Forst T, Nüssler AK, Braun KF, Ehnert S. Anti-diabetic treatment regulates pro-fibrotic TGF-beta serum levels in type 2 diabetics. Diabetol Metab Syndr. 2013;5:48-53. Go to original source... Go to PubMed...
    28. Srikanthan P, Crandall CJ, Miller-Martinez D, Seemann TE, Greendale GA, Brinkley N, Karlamangla AS. Insulin resistance and bone strength: findings from the study of midlife in the United States. J Bone Miner Res. 2014;29: 796-803. Go to original source... Go to PubMed...
    29. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int. 2007;18:427-444. Go to original source... Go to PubMed...
    30. Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia. 2005;48:1292-1299. Go to original source... Go to PubMed...
    31. Villafan-Bernal JR, Sanchez-Enriquez S, Munoz-Valle JF. Molecular modulation of osteocalcin and its relevance in diabetes (Review). Int J Mol Med. 2011;28:283-293.
    32. Vogt MT, Cauley JA, Tomaino MM, Stone K, Williams JR, Herndon JH. Distal radius fractures in older women: a 10-year follow-up study of descriptive characteristics and risk factors The study of osteoporotic fractures. J Am Geriatr Soc. 2002;50:97-103. Go to original source... Go to PubMed...
    33. Warriner AH, Patkar NM, Yun H, Delzell E. Minor, major low-trauma and high-trauma fractures: what are the subsequent fracture risks and how do they vary? Curr Osteoporos Rep. 2011;9:122-128. Go to original source... Go to PubMed...
    34. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053. Go to original source...
    35. Zinman B, Haffner SM, Herman WH, Holman RR, Lachin JM, Kravitz BG, Paul G, Jones NP, Aftring RP, Viberti G, Kahn SE, Adopt Study Group. Effect of rosiglitazone metformin and glyburide on bone biomarkers in patients with type 2 diabetes. J Clin Endocrinol Metab. 2010;95:134-142. Go to original source... Go to PubMed...

    Return to the content